News

May Webinar-Introducing Ovid & Graviton’s New ROCK2 Inhibitor for CCM

  Join us Thursday, May 16th at 7 pm ET/4 pm PT Learn about a ROCK2 Inhibitor medication being developed by Ovid Therapeutics and Graviton Bioscience with the potential to have a significant impact on the treatment of Cavernous Malformation. Join us for a conversation with Amy Melsaether, MD, Chief Medical Officer, Graviton BioScience, and…

April Volunteers of the Month: Allison and Amber

Join us in recognizing the volunteer efforts of Amber Brown and Allison Mintz, our Volunteers of the Month for April! Their dedication and enthusiasm have breathed new life into the Greater DC Alliance to Cure group. Through their efforts in organizing engaging get-togethers like a holiday potluck and a Rare Disease Day event, Allison and…

Exit mobile version